findmyKOL
Clinical trialNCT03477396CompletedPhase 2Interventional

Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

SponsorCity of Hope Medical CenterEnrollment2Estrogen Receptor and/or Progesterone Receptor PositiveHER2/Neu NegativeStage IV Breast Cancer AJCC v6 and v7
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope Corona

    Corona, California, United States

  • City of Hope Medical Center

    Duarte, California, United States

  • City of Hope Antelope Valley

    Lancaster, California, United States

  • City of Hope Mission Hills

    Mission Hills, California, United States

  • City of Hope Rancho Cucamonga

    Rancho Cucamonga, California, United States

  • City of Hope South Pasadena

    South Pasadena, California, United States

  • City of Hope West Covina

    West Covina, California, United States

  • Roswell Park Cancer Institute

    Buffalo, New York, United States

  • Wilmot Cancer Institute

    Rochester, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Jun 2018
Primary completion
29 Sept 2021
Completion
5 Jun 2023
Last update posted
20 Feb 2024
Registered enrollment
2
Registry id
NCT03477396

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.